Drug or technology

Alogliptin AND Metformin Hydrochloride

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 11, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Kazano (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for labeling change to an existing combination antidiabetic product; no clinical trial data or efficacy outcomes reported.

Regulatory UpdateTakeda Pharms U Alogliptin AND Metformin Hydrochloride